Compare · OPCH vs TDOC
OPCH vs TDOC
Side-by-side comparison of Option Care Health Inc. (OPCH) and Teladoc Health Inc. (TDOC): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both OPCH and TDOC operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- OPCH is the larger of the two at $4.22B, about 3.9x TDOC ($1.07B).
- Over the past year, OPCH is down 37.0% and TDOC is down 14.7% - TDOC leads by 22.3 points.
- Both names hit the wire about 6 times in the past 4 weeks.
- TDOC has more recent analyst coverage (25 ratings vs 13 for OPCH).
- Company
- Option Care Health Inc.
- Teladoc Health Inc.
- Price
- $20.32-24.32%
- $6.10+2.43%
- Market cap
- $4.22B
- $1.07B
- 1M return
- -24.53%
- +11.90%
- 1Y return
- -37.01%
- -14.66%
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NASDAQ
- NYSE
- IPO
- 2015
- News (4w)
- 6
- 6
- Recent ratings
- 13
- 25
Option Care Health Inc.
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides immunoglobulin infusion therapies for the treatment of immune deficiencies; anti-infective therapies and services; home infusion services to treat heart failures; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders; and immunoglobulin infusion therapies. It also offers infusion therapies for bleeding disorders; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications. In addition, the company offers therapies that women need to survive and thrive through high-risk pregnancies; treatments to manage the progression of neurological disorders, such as amyotrophic lateral sclerosis and duchenne muscular dystrophy; and nursing services. The company is headquartered in Bannockburn, Illinois.
Teladoc Health Inc.
Teladoc Health, Inc. provides virtual healthcare services on a business-to-business basis in the United States and internationally. It covers various clinical conditions, including non-critical, episodic care, chronic, and complicated cases like cancer and congestive heart failure, as well as offers telehealth solutions, chronic condition management, expert medical services, behavioral health solutions, guidance and support, and platform and program services. It serves health employers, health plans, hospitals, health systems, and insurance and financial services companies. The company offers its products and services under the Teladoc, Livongo, Advance Medical, Best Doctors, BetterHelp, and HealthiestYou brands. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was Incorporated in 2002 and is headquartered in Purchase, New York.
Latest OPCH
- Option Care Health Announces Financial Results for the First Quarter Ended March 31, 2026
- Option Care Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
- Chief Medical Officer Adewunmi Femi covered exercise/tax liability with 1,396 shares, decreasing direct ownership by 5% to 25,314 units (SEC Form 4)
- SEC Form DEFA14A filed by Option Care Health Inc.
- SEC Form DEF 14A filed by Option Care Health Inc.
- Option Care Health to Announce First Quarter 2026 Financial Results and Host Conference Call
- Option Care Health Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
- Amendment: SEC Form SCHEDULE 13G/A filed by Option Care Health Inc.
- Chief Human Resources Officer Bavaro Michael sold $198,000 worth of shares (6,000 units at $33.00), decreasing direct ownership by 15% to 33,249 units (SEC Form 4)
- Director Pate R Carter sold $970,620 worth of shares (30,287 units at $32.05), decreasing direct ownership by 72% to 11,623 units (SEC Form 4)
Latest TDOC
- SEC Form 10-Q filed by Teladoc Health Inc.
- Teladoc Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Teladoc Health Reports First Quarter 2026 Results
- Teladoc Health to Announce First Quarter 2026 Financial Results
- SEC Form DEF 14A filed by Teladoc Health Inc.
- SEC Form DEFA14A filed by Teladoc Health Inc.
- SEC Form 4 filed by Catapano Joseph Ronald
- SEC Form 4 filed by Salka Susan R
- SEC Form 3 filed by new insider Salka Susan R
- Teladoc Health Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits